Durability and Long-term Clinical Outcomes of Fecal Microbiota Transplant Treatment in Patients With Recurrent Clostridium difficile Infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Durability and Long-term Clinical Outcomes of Fecal Microbiota Transplant Treatment in Patients With Recurrent Clostridium difficile Infection

Published:2017-12-19 Issue:11 Volume:66 Page:1705-1711
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Mamo Yafet¹,Woodworth Michael H²,Wang Tiffany¹,Dhere Tanvi³,Kraft Colleen S²⁴

Affiliation:

1. Emory University School of Medicine, Atlanta, Georgia

2. Division of Infectious Diseases, Emory University, Atlanta, Georgia

3. Division of Digestive Diseases, Emory University, Atlanta, Georgia

4. Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia

Funder

National Center for Advancing Translational Sciences

National Institute of Allergy and Infectious Diseases

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/66/11/1705/25084144/cix1097.pdf

Reference36 articles.

1. Clostridium difficile-associated disease in U.S. hospitals, 1993–2005: statistical brief #50;Elixhauser,2006

2. Increasing incidence of multiply recurrent Clostridium difficile infection in the United States: a cohort study;Ma;Ann Intern Med,2017

3. Clostridium difficile infection: a review of the literature;Khan;Asian Pac J Trop Med,2014

4. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice;Lawley;PLoS Pathog,2012

5. Clostridium difficile-associated diseases. The clinical courses of 18 fatal cases;Siemann;Intensive Care Med,2000

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), Among Patients Exposed to Non–Clostridioides difficile Infection Antibiotics: Post Hoc Subgroup Analysis of a Phase 2 Open-Label Study;Open Forum Infectious Diseases;2024-06-17

2. Factors of faecal microbiota transplantation applied to cancer management;Journal of Drug Targeting;2024-01-04

3. The Next Generation: Mentoring and Diversity in the Antibacterial Resistance Leadership Group;Clinical Infectious Diseases;2023-10-15

4. CE: Current and Emerging Applications of Fecal Microbiota Transplantation;AJN, American Journal of Nursing;2023-10

5. Microbiome therapeutics for the treatment of recurrent Clostridioides difficile infection;Expert Opinion on Biological Therapy;2022-12-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3